BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Returns | |||||
| Return on Equity | 56.2% | 38.9% | -43.4% | -59.0% | |
| Return on Assets | -59.7% | -38.1% | -31.7% | -37.1% | |
| Return on Inv Capital | 44.9% | 34.1% | -38.4% | -50.9% | |
| Liquidity | |||||
| Current Ratio | 8.80x | 13.27x | 18.98x | 8.74x | |
| Quick Ratio | 8.80x | 13.27x | 18.98x | 8.74x | |
| Cash Ratio | 1.42x | 2.53x | 3.27x | 1.43x | |
| Leverage | |||||
| Debt / Equity | -0.06x | -0.02x | 0.32x | 0.50x | |
| Equity Multiplier | -0.94x | -1.02x | 1.37x | 1.59x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | 0.86x | 0.95x | 0.93x | 0.80x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--